Introduction The aim of this work is to evaluate baricitinib safety with respect to venous
thromboembolism (VTE), major adverse cardiovascular events (MACE), and serious …

Objective To assess and compare the incidence of venous thromboembolism (VTE) in
patients with rheumatoid arthritis (RA) treated with Janus kinase inhibitors (JAKi), tumour …

Importance The optimal pharmacologic thromboprophylaxis agent after total hip and total
knee arthroplasty is uncertain and consensus is lacking. Quantifying the risk of postoperative …

Aims The identification of venous thromboembolism (VTE) using administrative databases is
frequently required for reporting and research. The accuracy of International Classification of …

Objective There was a safety concern about an increased risk of thromboembolic events in
patients with rheumatoid arthritis (RA) treated with Janus kinase inhibitors (JAKis). This …

Aims Patients with inflammatory joint diseases (IJD), including rheumatoid arthritis (RA),
psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) have increased rates of …

There is a paucity of data regarding the contemporary temporal trends in the adoption of
advanced pulmonary embolism (PE) therapies in the United States as well as the parallel …

Background Postpartum psychiatric disorders (PPD) are common complications of childbirth.
A common explanation for their development is that the psychological, hormonal, and …

Objective The risk of venous thromboembolism (VTE) with feminizing gender-affirming
hormone therapy is an area of concern. This analysis aimed to assess whether gender …

Results: In the SCCS studies, the risk of cardiovascular disease was significantly increased
compared to the control period as follows: up to 14 days after COVID-19 for acute …